These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29398321)

  • 1. Navigating treatment controversies for DCIS in the era of genomic profiling and active surveillance trials.
    Kuerer HM
    Eur J Surg Oncol; 2018 Apr; 44(4):386-387. PubMed ID: 29398321
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the editor: Breast cancer in young women in Africa: are there genetic and clinical differences with European ancestry patients?
    Baltogiannis G; Roukos DH
    World J Surg; 2010 Aug; 34(8):1982-3. PubMed ID: 20130864
    [No Abstract]   [Full Text] [Related]  

  • 3. [Carcinoma in situ. Prognostic factors].
    Trojani M
    Arch Anat Cytol Pathol; 1994; 42(5):234-50. PubMed ID: 7872815
    [No Abstract]   [Full Text] [Related]  

  • 4. Ductal carcinoma in situ: state of the science and roadmap to advance the field.
    Kuerer HM; Albarracin CT; Yang WT; Cardiff RD; Brewster AM; Symmans WF; Hylton NM; Middleton LP; Krishnamurthy S; Perkins GH; Babiera G; Edgerton ME; Czerniecki BJ; Arun BK; Hortobagyi GN
    J Clin Oncol; 2009 Jan; 27(2):279-88. PubMed ID: 19064970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASO Author Reflections: Active Surveillance for Ductal Carcinoma In Situ (DCIS).
    Oseni TO; Bahl M
    Ann Surg Oncol; 2020 Oct; 27(11):4466-4467. PubMed ID: 32440718
    [No Abstract]   [Full Text] [Related]  

  • 6. The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS).
    Hwang ES; Hyslop T; Lynch T; Frank E; Pinto D; Basila D; Collyar D; Bennett A; Kaplan C; Rosenberg S; Thompson A; Weiss A; Partridge A
    BMJ Open; 2019 Mar; 9(3):e026797. PubMed ID: 30862637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ductal carcinoma in situ of the breast.
    Fonseca R; Hartmann LC; Petersen IA; Donohue JH; Crotty TB; Gisvold JJ
    Ann Intern Med; 1997 Dec; 127(11):1013-22. PubMed ID: 9412283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should patients with ductal carcinoma in situ be treated with adjuvant whole breast radiotherapy after breast conservation surgery?
    Bagenal J; Roche N; Ross G; Kirby A; Dodwell D
    BMJ; 2018 May; 361():k1410. PubMed ID: 29773535
    [No Abstract]   [Full Text] [Related]  

  • 9. Ductal Carcinoma In Situ: The Whole Truth.
    Parikh U; Chhor CM; Mercado CL
    AJR Am J Roentgenol; 2018 Feb; 210(2):246-255. PubMed ID: 29045181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology and clinical evolution of ductal carcinoma in situ (DCIS) of the breast.
    Page DL; Lagios MD
    Cancer Lett; 1994 Oct; 86(1):1-4. PubMed ID: 7954344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National treatment trends for ductal carcinoma in situ of the breast. Arch Surg 1997 Jun;132:660-665.
    Morrow M
    J Womens Health; 1998 Mar; 7(2):267-8. PubMed ID: 9555693
    [No Abstract]   [Full Text] [Related]  

  • 12. Crossroads in breast cancer: the intersection of clinical uncertainty and molecular profiling.
    Farina K
    Am J Manag Care; 2013; 19(1 Spec No):SP19-20. PubMed ID: 23461468
    [No Abstract]   [Full Text] [Related]  

  • 13. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer.
    Goldhirsch A; Glick JH; Gelber RD; Coates AS; Senn HJ
    J Clin Oncol; 2001 Sep; 19(18):3817-27. PubMed ID: 11559719
    [No Abstract]   [Full Text] [Related]  

  • 14. Ductal carcinoma in situ of the breast: progress and controversy.
    Swallow CJ; Van Zee KJ; Sacchini V; Borgen PI
    Curr Probl Surg; 1996 Jul; 33(7):553-600. PubMed ID: 8765465
    [No Abstract]   [Full Text] [Related]  

  • 15. New method to predict DCIS recurrence.
    Printz C
    Cancer; 2013 Nov; 119(22):3899. PubMed ID: 24590902
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of aberrant gene expression during breast ductal carcinoma
    Song G; He L; Yang X; Yang Y; Cai X; Liu K; Feng G
    J Int Med Res; 2020 Jan; 48(1):300060518815364. PubMed ID: 30712460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Third meeting of the DCIS Working Party of the EORTC (Fondazione Cini, Isola S. Giorgio, Venezia, 28 February 1994)--Conference report.
    Recht A; van Dongen JA; Fentiman IS; Holland R; Peterse JL
    Eur J Cancer; 1994; 30A(12):1895-900. PubMed ID: 7533509
    [No Abstract]   [Full Text] [Related]  

  • 18. New clinical trials under way for DCIS.
    Blume E
    J Natl Cancer Inst; 1997 Aug; 89(15):1094. PubMed ID: 9262243
    [No Abstract]   [Full Text] [Related]  

  • 19. Controversies in the treatment of ductal carcinoma in situ.
    Hughes KS; Lee AK; Rolfs A
    Surg Clin North Am; 1996 Apr; 76(2):243-65. PubMed ID: 8610262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of the biology and management of ductal carcinoma in situ of the breast.
    Frykberg ER; Bland KI
    Cancer; 1994 Jul; 74(1 Suppl):350-61. PubMed ID: 8004607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.